Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS
PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis
PDF) Polo-like kinase 4 activity limits centrosome overduplication by autoregulating its own stability
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research
Molecules | Free Full-Text | Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors
PLK Inhibition | PLK Activation | PLK Inhibitor Review
PDF) Polo-like kinase 4: The odd one out of the family
PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis
Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science
Rabbit anti-Human PLK4 antibody (ABIN2682502)
Targeting polo-like kinase 1 for cancer therapy | Nature Reviews Cancer
Transient changes in the levels of polo-like kinase (Plk) 4 and... | Download Scientific Diagram
Figure 3 from Polo-like kinases: structural variations lead to multiple functions | Semantic Scholar
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers | PNAS
Figure 3 from Polo-like kinase 4: the odd one out of the family | Semantic Scholar
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
Polo-like Kinase Inhibitor V, Poloxin - CAS 321688-88-4 - Calbiochem The Polo-like Kinase Inhibitor
Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy? - ScienceDirect
Role for polo-like kinase 4 in mediation of cytokinesis | PNAS
Autoinhibition and relief mechanism for Polo-like kinase 4 – The Quan Lab
Polo-like Kinase 4 Shapes Up - ScienceDirect
Figure 2 from Polo-like kinase 4: the odd one out of the family | Semantic Scholar
Reversible centriole depletion with an inhibitor of Polo-like kinase 4 | Science
